SALL2-Mediated Suppression of WNT Signaling Through Transcriptional Control of AXIN2 in Colorectal Cancer Cells

Area of Science:

• Oncology
• Molecular Biology
• Cancer Signaling Pathways

Background:

• Colorectal cancer (CRC) is a major global health concern, with Wnt/β-catenin pathway activation driving tumor growth.
• The role of the zinc finger transcription factor SALL2 in human CRC pathogenesis is not well understood.
• Previous studies suggest SALL2's involvement in Wnt signaling regulation in other species.

Purpose of the Study:

• To investigate the expression pattern and functional significance of SALL2 in colorectal cancer.
• To determine the relationship between SALL2 expression, Wnt/β-catenin signaling activity, and patient prognosis.
• To explore SALL2's potential as a therapeutic target in CRC.

Main Methods:

• Immunohistochemical analysis of SALL2 expression in normal colon tissue, adenomas, carcinomas, and CRC cell lines.
• Assessing the correlation between SALL2 levels, active β-catenin, and patient survival outcomes.
• Functional assays, including chromatin immunoprecipitation and promoter-reporter assays, to elucidate SALL2's mechanism of action on AXIN2.
• Evaluating the effect of SALL2 expression on CRC cell apoptosis in response to Wnt pathway inhibition.

Main Results:

• SALL2 expression is significantly downregulated in colorectal adenomas, carcinomas, and CRC cell lines compared to normal colon tissue.
• Lower SALL2 levels correlate with increased active β-catenin and poorer patient survival.
• SALL2 directly binds to the AXIN2 promoter, transcriptionally activating its expression.
• SALL2 enhances the pro-apoptotic effects of Wnt pathway inhibitors in CRC cells.

Conclusions:

• SALL2 acts as a negative regulator of the Wnt/β-catenin signaling pathway in colorectal cancer.
• Reduced SALL2 expression is a potential biomarker for poor prognosis in CRC.
• SALL2 represents a promising therapeutic target for sensitizing CRC cells to Wnt-targeted therapies.